Melanoma: treatment guidelines for patients (part 2).
The mutual goal of the National Comprehensive Cancer Network (NCCN) and the American Cancer Society partnership is to provide patients and the generalpublic with state of the art cancer treatment information in understandable language. This treatment information is based on the professional guidelines developed by the NCCN. It is intended to assist patients in a discussion with their doctor about the treatment that is best for their specific situation. Part I of these guidelines addressed melanoma risk factors, prevention, diagnosis, stages, prevention, and clinical trials (Vol. 17, No 2, pp. 119-131). Part II describes decision trees for evaluation and treatment.
D000359:Aftercare / Q000592:standards; D001706:Biopsy / Q000592:standards; D003131:Combined Modality Therapy / Q000592:standards; D003663:Decision Trees; D006801:Humans; D008487:Medical History Taking / Q000592:standards; D008545:Melanoma / Q000175:diagnosis / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000628:therapy; D009367:Neoplasm Staging / Q000592:standards; D010808:Physical Examination / Q000592:standards; D012878:Skin Neoplasms / Q000175:diagnosis / Q000628:therapy